Submit Manuscript  

Article Details


Overexpression of Nemo-like Kinase Promotes the Proliferation and Invasion of Lung Cancer Cells and Indicates Poor Prognosis

[ Vol. 18 , Issue. ]

Author(s):

Lei Lei, Yuan Wang, Yi-Wen Zheng, Liang-Ru Fei, Hao-Yue Shen, Zhi-Han Li, Wen-Jing Huang, Juan-Han Yu and Hong-Tao XuPages 1-7 (7)

Abstract:


Nemo-like kinase (NLK) is an evolutionarily conserved MAP kinase–related kinase involved in the pathogenesis of several human cancers. We examined the expression of NLK in lung cancer tissues through western blot analysis. We enhanced or knocked down NLK expression by gene transfection or RNA interference, respectively, in lung cancer cells and examined expression alterations of key proteins in the Wnt signaling pathway and in epithelial–mesenchymal transition (EMT). We also examined the roles of NLK in the proliferation and invasiveness of lung cancer cells by cell proliferation, colony formation, and Matrigel invasion assays. NLK expression was found to be significantly higher in lung cancer tissue samples than in corresponding healthy lung tissue samples. Overexpression of NLK correlated with poor prognosis of patients with lung cancer. Overexpression of NLK upregulated β-catenin, TCF4, and Wnt target genes such as cyclin D1, c- Myc, and MMP7. N-cadherin and TWIST, the key proteins in EMT, were upregulated, while Ecadherin expression was reduced. Additionally, proliferation, colony formation, and invasion turned out to be enhanced in NLK-overexpressing cells. After NLK knockdown in lung cancer cells, we obtained the opposite results. In conclusion, NLK is overexpressed in lung cancers and indicates poor prognosis. Overexpression of NLK activates the Wnt signaling pathway and EMT and promotes the proliferation and invasiveness of lung cancer cells.

Keywords:

Nemo-like kinase, Lung cancer, Wnt signaling pathway, Epithelial to mesenchymal transition, Proliferation, Invasion

Affiliation:

Department of Pathology, College of Basic Medical Sciences and the First Hospital, China Medical University, Shenyang 110001, Department of Pathology, College of Basic Medical Sciences and the First Hospital, China Medical University, Shenyang 110001, Department of Pathology, College of Basic Medical Sciences and the First Hospital, China Medical University, Shenyang 110001, Department of Pathology, College of Basic Medical Sciences and the First Hospital, China Medical University, Shenyang 110001, 100K80B, Clinical medicine of seven-year programme, China Medical University, Shenyang 110001, Department of Pathology, College of Basic Medical Sciences and the First Hospital, China Medical University, Shenyang 110001, Department of Pathology, College of Basic Medical Sciences and the First Hospital, China Medical University, Shenyang 110001, Department of Pathology, College of Basic Medical Sciences and the First Hospital, China Medical University, Shenyang 110001, Department of Pathology, College of Basic Medical Sciences and the First Hospital, China Medical University, Shenyang 110001



Read Full-Text article